The global veterinary medicine market is anticipated to reach market size of around US$ 29,000 Mn by 2027 and is anticipated to grow at a CAGR of around 5% in terms of revenue during the forecast period 2020 – 2027.
Each substance for the treatment of different medical problems in animals is referred to as veterinary medicine. For instance, veterinary medications include medications that can be delivered orally on animals, such as anti-infection drugs and parasiticides. Similarly, veterinary medicine also contains vaccines used in animals for immunity from multiple infectious diseases, such as Equine Flu (EIV) and 3-respiratory syncytial parainfluenza. They also include medicated feed additives combined with animal feed for medicinal results in livestock. In addition , medical care is applied in different animal forms, including associated livestock like dogs and cats and cattle such as bovine cows , pigs and poultry. In addition, treatment is used in animals on multiple routes such as oral administering of medications, parenteral injection, and topical administration of certain parasiticidal medications.
Market Insights
Increased numbers of livestock owners and boosting the livestock population globally are among the main drivers in the advancement of the veterinary medicine industry. In addition, factors like the increase in the prevalence and rise in demand for livestock products with different medical problems in animals also fuel the market growth with veterinary medicine. In addition, increased spending on animal welfare is another significant factor driving demand growth. However, lack of veterinary facilities in underdeveloped countries and stringent regulations pertaining to medicinal feed additives hinder demand development in veterinary medicines. Instead, growing knowledge of animal welfare gives the industry of veterinary medicine a profitable opportunity.
In comparison, COVID-19 has had a negative impact on the market. For instance, countries around the world introduced national locks in place after the WHO declared COVID-19 a pandemic as a way of regulating social distance. In each field of every industry, there are disturbances, restrictions, threats and improvements. In addition, the pandemic also threatened the veterinary medicines sector. Veterinary associations around the world , for instance, have recommended that animal patient care be limited to acutely diseased animals and emergencies. In addition, the lockdowns culminated in the annual control and elective procedures being re-scheduled. However, several major actors have ensured the availability of veterinary drugs as government agencies around the world take rigorous availability maintenance steps. Therefore, overall effect of COVID-19 on the veterinary industry remains reasonably negative, owing to decline in demand as veterinary visits are reduced and animal healthcare strategy is shifted to providing treatment to emergency cases and critically sick animals.
The veterinary medicine market was led by North America, representing a share of more than 38.5% of global sales in 2019. The European countries are dominant due to beneficial legislation of the government including the EU regulation on veterinary medicine and the expanded acceptance in European countries of pet insurance. The increasing prevalence of zoonotic diseases and favourable reimbursement initiatives are important factors attributable to dominance. In addition, growing acceptance of pet health insurance in the U.S. can also allow the demand in veterinary pharmaceuticals to expand. The demand is anticipated to expand profitably in Asia-Pacific over the projected period. Markets in the area have been promoted by factors such as increased acceptance of accompanying livestock and an increase in welfare issues for livestock. In addition, increased spending on animal, medical, and cattle care is driving the veterinary medicine industry.
Some of the prominent players in the veterinary medicine market include Intravet INC. (MERCK AND CO., INC.), Zoetis, Elanco, Bayer AG, Ceva, Vetoquinol India Animal Health Pvt Ltd, Virbac, Boehringer Ingelheim International GmbH, Nutreco N.V, Sanofi, and others.
The global veterinary medicine market is segmented as below:
Market Segmentation
Veterinary Medicine Market By Product
Drugs
- Anti-infective
- Anti-inflammatory
- Parasiticide
Vaccines
- Inactivated Vaccines
- Attenuated Vaccines
- Recombinant Vaccines
Medicated Feed Additives
Veterinary Medicine Market By Route of Administration
Companion Animals
Livestock Animals
Veterinary Medicine Market By Distribution Channel
Veterinary Hospital Pharmacies
Retail Veterinary Pharmacies
Veterinary Medicine Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Veterinary Medicine
1.1. Definition and Scope
1.1.1. Definition of Veterinary Medicine
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Veterinary Medicine Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Veterinary Medicine Market By Product
1.2.3. Veterinary Medicine Market By Route of Administration
1.2.4. Veterinary Medicine Market By Distribution Channel
1.2.5. Veterinary Medicine Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Route of Administration
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio And Market Maturity Analysis of Veterinary Medicine Market
3.5.1. Go To Market Strategy
3.6. Technological Roadmap for Veterinary Medicine Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date Global for Veterinary Medicine Major Manufacturers in 2019
4.2. R&D Status and By Route of Administration Route of Administration of Global Veterinary Medicine Major Manufacturers in 2019
CHAPTER 5. Veterinary Medicine Market By Product
5.1. Introduction
5.2. Veterinary Medicine Revenue By Product
5.2.1. Veterinary Medicine Revenue (US$ Mn) and Forecast, By Product, 2016-2027
5.2.2. Drugs
5.2.2.1. Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.1. Anti-infective
5.2.2.1.1.1. Anti-infective Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.2. Anti-inflammatory
5.2.2.1.2.1. Anti-inflammatory Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.3. Parasiticide
5.2.2.1.3.1. Parasiticide Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Vaccines
5.2.3.1. Vaccines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.1.1. Inactivated Vaccines
5.2.3.2. Inactivated Vaccines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.2.1. Attenuated Vaccines
5.2.3.3. Attenuated Vaccines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.3.1. Recombinant Vaccines
5.2.3.4. Recombinant Vaccines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Medicated Feed Additives
5.2.4.1. Medicated Feed Additives Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4.1.1. Amino Acids
5.2.4.2. Amino Acids Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4.2.1. Antibiotics
5.2.4.3. Antibiotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Veterinary Medicine Market Revenue By Route of Administration
6.1. Introduction
6.2. Veterinary Medicine Revenue (US$ Mn) By Route of Administration
6.2.1. Veterinary Medicine Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
6.2.2. Oral Route
6.2.2.1. Oral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Parenteral Route
6.2.3.1. Parenteral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Topical Route
6.2.4.1. Topical Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Veterinary Medicine Market By Distribution Channel
7.1. Introduction
7.2. Veterinary Medicine Revenue (US$ Mn) By Distribution Channel
7.2.1. Veterinary Medicine Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
7.2.2. Veterinary Hospital Pharmacies
7.2.2.1. Veterinary Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Retail Veterinary Pharmacies
7.2.3.1. Retail Veterinary Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Veterinary Medicine Market By Country
8.1. North America Veterinary Medicine Overview
8.2. U.S.
8.2.1. U.S. Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.S. Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.2.3. U.S. Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Canada
8.3.1. Canada Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Canada Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.3.3. Canada Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Veterinary Medicine Market By Country
9.1. Europe Bioanlytical Testing Services Market Overview
9.2. U.K.
9.2.1. U.K. Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.2.2. U.K. Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.2.3. U.K. Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Germany
9.3.1. Germany Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.3.2. Germany Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.3.3. Germany Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. France
9.4.1. France Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.4.2. France Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.4.3. France Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.5. Spain
9.5.1. Spain Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.5.2. Spain Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.5.3. Spain Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.6.2. Rest of Europe Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.6.3. Rest of Europe Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Veterinary Medicine Market By Country
10.1. Asia Pacific Veterinary Medicine Market Overview
10.2. China
10.2.1. China Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. China Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.2.3. China Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. Japan
10.3.1. Japan Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Japan Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.3.3. Japan Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. India
10.4.1. India Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.2. India Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.4.3. India Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.5. Australia
10.5.1. Australia Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.5.2. Australia Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.5.3. Australia Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.6.2. South Korea Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.6.3. South Korea Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.7.2. Rest of Asia-Pacific Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.7.3. Rest of Asia-Pacific Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Veterinary Medicine Market By Country
11.1. Latin America Veterinary Medicine Market Overview
11.2. Brazil
11.2.1. Brazil Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Brazil Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.2.3. Brazil Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. Mexico Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.3.3. Mexico Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Latin America Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 – 2027
11.4.3. Rest of Latin America Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 12. Middle East & Africa Veterinary Medicine Market By Country
12.1. Middle East & Africa Veterinary Medicine Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.2.2. Saudi Arabia Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.2.3. Saudi Arabia Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.3. UAE
12.3.1. UAE Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.3.2. UAE Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.3.3. UAE Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.4.2. Rest of Middle East & Africa Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.4.3. Rest of Middle East & Africa Veterinary Medicine Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 13. PLAYER ANALYSIS OF STROKE MANAGEMENT
13.1. Veterinary Medicine Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Route of Administration Launches and Route of Administration Enhancements
13.2.3. Mergers And Acquisition In Global Veterinary Medicine Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Intravet INC.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Intravet INC. 2019 Veterinary Medicine Business Regional Distribution
14.1.4. Route of Administration/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Zoetis
14.3. Elanco
14.4. Bayer AG
14.5. Ceva
14.6. Vetoquinol India Animal Health Pvt Ltd
14.7. Virbac
14.8. Boehringer Ingelheim International GmbH
14.9. Nutreco N.V
14.10. Sanofi
14.11. Others
![Veterinary Medicine Market (By Product: Drugs [Anti-infective, Anti-inflammatory, Parasiticide], Vaccines [Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines], Medicated Feed Additives [Amino Acids, Antibiotics]; By Route of Administration: Companion Animals, Livestock Animals; By Distribution Channel: Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027](assets/images/format-png.png "Veterinary Medicine Market (By Product: Drugs [Anti-infective, Anti-inflammatory, Parasiticide], Vaccines [Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines], Medicated Feed Additives [Amino Acids, Antibiotics]; By Route of Administration: Companion Animals, Livestock Animals; By Distribution Channel: Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027")
